Cost-effectiveness of Universal BRCA1/2 Screening Evidence-Based Decision Making

被引：30
|
作者：
Long, Elisa F. [1 ]
Ganz, Patricia A. [2 ,3 ,4 ]
机构：
[1] Univ Calif Los Angeles, Anderson Sch Management, 110 Westwood Plaza,Ste B508, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Div Canc Prevent & Control Res, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA
[4] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA
来源：
JAMA ONCOLOGY | 2015年 / 1卷 / 09期
关键词：
MUTATION CARRIERS; MAMMOGRAPHY; POPULATION;
D O I：
10.1001/jamaoncol.2015.2340
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1217 / 1218
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers
    Pataky, Reka
    Armstrong, Linlea
    Chia, Stephen
    Coldman, Andrew J.
    Kim-Sing, Charmaine
    McGillivray, Barbara
    Scott, Jenna
    Wilson, Christine M.
    Peacock, Stuart
    BMC CANCER, 2013, 13
  • [2] Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers
    Reka Pataky
    Linlea Armstrong
    Stephen Chia
    Andrew J Coldman
    Charmaine Kim-Sing
    Barbara McGillivray
    Jenna Scott
    Christine M Wilson
    Stuart Peacock
    BMC Cancer, 13
  • [3] Cost-effectiveness of genetic testing for BRCA1 and BRCA2 mutations
    Ozanne, E. M.
    Cipriano, L.
    Cameron, M.
    Newman, T.
    Esserman, L. J.
    CANCER RESEARCH, 2009, 69 (02) : 377S - 377S
  • [4] Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging
    Plevritis, Sylvia K.
    Kurian, Allison W.
    Sigal, Bronislava M.
    Daniel, Bruce L.
    Ikeda, Debra M.
    Stockdale, Frank E.
    Garber, Alan M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (20): : 2374 - 2384
  • [5] Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation
    Anderson, K
    Jacobson, JS
    Heitjan, DF
    Zivin, JG
    Hershman, D
    Neugut, AI
    Grann, VR
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (06) : 397 - 406
  • [6] Testing for BRCA1 mutations: a cost-effectiveness analysis
    Christine Sevilla
    Jean-Paul Moatti
    Claire Julian-Reynier
    François Eisinger
    Dominique Stoppa-Lyonnet
    Brigitte Bressac-de Paillerets
    Hagay Sobol
    European Journal of Human Genetics, 2002, 10 : 599 - 606
  • [7] Testing for BRCA1 mutations: a cost-effectiveness analysis
    Sevilla, C
    Moatti, JP
    Julian-Reynier, C
    Eisinger, F
    Stoppa-Lyonnet, D
    Bressac-de Paillerets, B
    Sobol, H
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (10) : 599 - 606
  • [8] Incorporating information about cost-effectiveness into evidence-based decision-making - The Evidence-Based Practice Center (EPC) model
    Helfand, M
    MEDICAL CARE, 2005, 43 (07) : 33 - 43
  • [9] Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer preventionCost-effectiveness of BRCA1 testing at time of obstetrical
    Dioun, Shayan
    Perez, Luiza
    Sharaf, Ravi
    Hou, June
    Wright, Jason D.
    Prabhu, Malavika
    Frey, Melissa
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 230 (01) : S236 - S237
  • [10] Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness
    G H de Bock
    K M Vermeulen
    L Jansen
    J C Oosterwijk
    S Siesling
    M D Dorrius
    T Feenstra
    N Houssami
    M J W Greuter
    British Journal of Cancer, 2013, 108 : 1579 - 1586
12345